Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Return on Sales (2024 - 2025)

Historic Return on Sales for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to 3.57%.

  • Kura Oncology's Return on Sales fell 1356200.0% to 3.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.32%, marking a year-over-year change of. This contributed to the annual value of 3.23% for FY2024, which is 1017600.0% down from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Return on Sales is 3.57%, which was down 1356200.0% from 4.33% recorded in Q2 2025.
  • Kura Oncology's 5-year Return on Sales high stood at 132.05% for Q3 2024, and its period low was 4.33% during Q2 2025.